InvAscent

Premium
Why Indian bulk-drug makers are attracting greater investor interest

Healthcare

06 November, 2019

Why Indian bulk-drug makers are attracting greater investor interest

Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry...

Premium

Healthcare

05 November, 2019

Healthcare PE firm InvAscent bets on woman and child care hospital

Healthcare private equity firm InvAscent has stepped into a new single-speciality segment with a fourth deal from its latest fund...

Premium

Healthcare

11 July, 2019

KIMS Hospitals in advanced stage to buy PE-backed regional hospital chain

Krishna Institute of Medical Sciences (KIMS Hospitals), which struck a deal with General Atlantic after withdrawing its initial...

Premium

Healthcare

31 January, 2019

InvAscent's third fund strikes two more deals; hits final close

Healthcare private equity firm InvAscent has struck two new deals from its third fund that just marked its final close, ......

Healthcare

18 December, 2018

Entrust Family Office invests in skincare clinic chain Oliva

Bengaluru-based Entrust Family Office Investment Advisors, an advisory firm that offers investment services to high-net-worth...

Healthcare

18 December, 2018

Motilal Oswal PE-InvAscent consortium buys out Actis from Symbiotec

A consortium of mid-market private equity firms InvAscent and Motilal Oswal PE has bought British PE firm Actis' entire stake...

Premium

Healthcare

22 November, 2018

InvAscent topping up oversubscribed healthcare PE fund

Healthcare private equity firm InvAscent is set to add more money to its India-focused third fund before hitting the final ......

Premium

Healthcare

22 November, 2018

Tata Capital targets bigger corpus for second healthcare private equity fund

Tata Capital Ltd has formally kicked off a process to mobilise capital for its second healthcare private equity fund, targeting...

Premium

Healthcare

20 September, 2018

Mid-market PE consortium in talks to buy Actis' stake in Symbiotec

Actis Advisers Pvt. Ltd is in the final stages of negotiations with a consortium of fellow private equity firms to ......

Premium

Healthcare

20 August, 2018

Evolvence India Life Sciences Fund fully exits Chennai drugmaker

Evolvence India Life Sciences Fund, the debut healthcare fund managed by private equity firm InvAscent, has fully exited its nine-year-old...

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News